Molecular Diagnostics - New tools for evidence-based medicine
The medical diagnostic (Dx) sector is playing a central role in the shifting health care and drug discovery landscape. Energized by the demand for changes in health care and driven by a wave of molecular advances, the Dx sector is responding with innovative new tools and technologies.
This report highlights some of the developments fueling this industry -- accomplishments and promise as well as the challenges facing the sector.
Discussion
Browse all reports
- A Bright Future for Diagnostic Imaging in Ontario
- Enterprise Software Applications: Opportunities for Ontario's software start-ups
- MaRS reports
- Molecular Diagnostics - New tools for evidence-based medicine
- Neurotechnology: Focus on Aging
- Regenerative Medicine: Industry Briefing
- Social Entrepreneurship: Legislative innovations
- Social Entrepreneurship: Social venture finance
- The Business of Social Networking: A MaRS market snapshot
